Results 1 to 10 of about 5,743 (138)
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium [PDF]
The Lancet: Digital Health, 2023 Summary: Background: The Invasive Respiratory Infection Surveillance (IRIS) Consortium was established to assess the impact of the COVID-19 pandemic on invasive diseases caused by Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, David Shaw, MBBCh, Raquel Abad, PhD, Zahin Amin-Chowdhury, MSc, Adriana Bautista, MSc, Desiree Bennett, PhD, Karen Broughton, MSc, Bin Cao, ProfMD, Carlo Casanova, PhD, Eun Hwa Choi, ProfMD, Yiu-Wai Chu, PhD, Heike Claus, PhD, Juliana Coelho, PhD, Mary Corcoran, PhD, Simon Cottrell, PhD, Robert Cunney, MB, Lize Cuypers, PhD, Tine Dalby, PhD, Heather Davies, NZCS, Linda de Gouveia, NatDipMedTech, Ala-Eddine Deghmane, PhD, Walter Demczuk, BSc, Stefanie Desmet, PhD, Mirian Domenech, PhD, Richard Drew, MD, Mignon du Plessis, PhD, Carolina Duarte, PhD, Helga Erlendsdóttir, ProfMSc, Norman K Fry, PhD, Kurt Fuursted, MD, Thomas Hale, ProfPhD, Desiree Henares, PhD, Birgitta Henriques-Normark, ProfMD, Markus Hilty, PhD, Steen Hoffmann, MD, Hilary Humphreys, ProfMD, Margaret Ip, ProfMSc, Susanne Jacobsson, PhD, Christopher Johnson, PhD, Jillian Johnston, MBBS, Keith A Jolley, PhD, Aníbal Kawabata, Jana Kozakova, MD, Karl G Kristinsson, ProfMD, Pavla Krizova, MD, Alicja Kuch, PhD, Shamez Ladhani, MD, Thiên-Trí Lâm, MD, María Eugenia León, MSc, Laura Lindholm, MSc, David Litt, PhD, Martin C J Maiden, ProfPhD, Irene Martin, BSc, Delphine Martiny, ProfPhD, Wesley Mattheus, PhD, Noel D McCarthy, ProfDPhil, Mary Meehan, PhD, Susan Meiring, MBChB, Paula Mölling, PhD, Eva Morfeldt, PhD, Julie Morgan, HND, Robert Mulhall, PhD, Carmen Muñoz-Almagro, ProfMD, David Murdoch, ProfMD, Joy Murphy, BA Hons, Martin Musilek, PhD, Alexandre Mzabi, MD, Ludmila Novakova, MSc, Shahin Oftadeh, PhD, Amaresh Perez-Argüello, MLT, Maria Pérez-Vázquez, PhD, Monique Perrin, MD, Malorie Perry, MSc, Benoit Prevost, PhD, Maria Roberts, BSc(Hons), Assaf Rokney, PhD, Merav Ron, PhD, Olga Marina Sanabria, MPH, Kevin J Scott, PhD, Carmen Sheppard, PhD, Lotta Siira, PhD, Vitali Sintchenko, ProfPhD, Anna Skoczyńska, ProfPhD, Monica Sloan, Hans-Christian Slotved, DMSc, Andrew J Smith, ProfFRCPath, Anneke Steens, PhD, Muhamed-Kheir Taha, ProfMD, Maija Toropainen, PhD, Georgina Tzanakaki, ProfPhD, Anni Vainio, PhD, Mark P G van der Linden, PhD, Nina M van Sorge, ProfPhD, Emmanuelle Varon, MD, Sandra Vohrnova, MD, Anne von Gottberg, ProfPhD, Jose Yuste, PhD, Rosemeire Zanella, PhD, Fei Zhou, PhD, Angela B Brueggemann, ProfDPhil +98 moredoaj +17 more sourcesSustained reductions in life-threatening invasive bacterial diseases during the first two years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries participating in the IRIS Consortium
, 2022 SummaryBackgroundThe Invasive Respiratory Infection Surveillance (IRIS) Consortium was established to assess the impact of the COVID-19 pandemic on invasive diseases caused byStreptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidisandStreptococcus agalactiae. Here we analyse the incidence and distribution of disease during the first two Shaw D, Abad R, Abad R, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, Cao B, Casanova C, Choi EH, Chu Y, Claus H, Coelho J, Corcoran M, Cottrell S, Cunney R, Cuypers L, Dalby T, Davies H, de Gouveia L, Deghmane A, Demczuk W, Desmet S, Domenech M, Drew R, du Plessis M, Duarte C, Erlendsdóttir H, Fry N, Fuursted K, Hale T, Henares D, Henriques-Normark B, Hilty M, Hoffmann S, Humphreys H, Ip M, Jacobsson S, Johnson C, Johnston J, Jolley KA, Kawabata A, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani S, Lâm T, María Eugenia L, Lindholm L, Litt D, Maiden MC, Martin I, Martiny D, Mattheus W, McCarthy ND, McElligott M, Meehan M, Meiring S, Mölling P, Morfeldt E, Morgan J, Mulhall R, Muñoz-Almagro C, Murdoch D, Murphy J, Musilek M, Mzabi A, Novakova L, Oftadeh S, Perez-Arguello A, Pérez-Vázquez M, Perrin M, Perry M, Prevost B, Roberts M, Rokney A, Ron M, Sanabria OM, Scott KJ, Sheppard C, Siira L, Sintchenko V, Skoczyńska A, Sloan M, Slotved H, Smith AJ, Steens A, Taha M, Toropainen M, Tzanakaki G, Vainio A, van der Linden MP, van Sorge NM, Varon E, Vohrnova S, Gottberg Av, Yuste J, Zanella R, Zhou F, Brueggemann AB. +100 moreeuropepmc +2 more sourcesAmerican Academy of Ophthalmology Intelligent Research in Sight (IRIS®) Registry and the IRIS Registry Analytic Center Consortium [PDF]
Ophthalmology Science, 2022 Cecilia S. Lee, MD, MS, Marian Blazes, MD, Alice Lorch, MD, MPH, Suzann Pershing, MD, MS, Leslie Hyman, PhD, Allen C. Ho, MD, FACS, Julia Haller, MD, Joan W. Miller, MD, Emily Y. Chew, MD, Flora Lum, MD, Aaron Y. Lee, MD, MSCI +10 moredoaj +3 more sourcesQuantifying the impact of the COVID-19 pandemic on invasive bacterial diseases across 27 countries and territories: prospective surveillance by the IRIS Consortium
Summary Background Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis are leading causes of invasive bacterial disease worldwide. The aims of this study were to measure post-COVID-19 pandemic changes in the incidence of disease caused by these bacterial pathogens and Shaw D, Abad R, Almeida SC, Amin-Chowdhury Z, Bautista A, Bennett D, Bradley D, Broughton K, Casanova C, Choi EH, Claus H, Corcoran M, Cottrell S, Cunney R, Cuypers L, Dalby T, Davies H, de Gouveia L, Deghmane A, Desmet S, Dickson E, Domenech M, Drew R, Duarte C, du Plessis M, Erlendsdóttir H, Fuursted K, Golden A, Henares D, Henriques-Normark B, Hilty M, Hoffmann S, Honskus M, Humphreys H, Jacobsson S, Johnson C, Jolley KA, Kawabata A, Kealy N, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani SN, Lâm T, León Ayala ME, Lindholm L, Litt D, Maiden MC, Martin I, Martiny D, Mattheus W, McCarthy ND, Meehan M, Meiring S, Moganeradj K, Mölling P, Morfeldt E, Morgan J, Mulhall R, Muñoz-Almagro C, Murdoch D, Murphy J, Musilek M, Novakova L, Oftadeh S, Okonji Z, Perez-Argüello A, Pérez-Vázquez MD, Perrin M, Perry M, Prevost B, Primitz JV, Ren U, Roberts M, Rokney A, Ron M, Sanabria OM, Scott KJ, Sempere J, Siira L, de Lemos APS, Sintchenko V, Skoczyńska A, Sloan M, Slotved H, Smith AJ, Steens A, Taha M, Toropainen M, Tzanakaki G, Vainio A, van der Linden MP, van Sorge NM, Varon E, Vazquez J, Vohrnova S, von Gottberg A, Yuste J, Zanella R, Brueggemann AB. +100 moreeuropepmc +2 more sourcesReirradiation treatment effects in the clinic (ReTEC) proposal - proof of concept based on spinal cord dose tolerance for reirradiation with stereotactic body radiotherapy. [PDF]
J Appl Clin Med PhysAbstract Background
Since the inception of spinal radiosurgery decades ago, the factors influencing spinal cord recovery have remained unclear. Elucidating these factors would aid in reirradiation planning and delivery. We describe modeling reirradiation normal tissue complication probabilities (NTCP) from compiled published data, akin to the ...Grimm J, Mahadevan A, Obayomi-Davies O, Soltys SG, Sahgal A, Redmond KJ, Milano MT, Tomé WA, Brooks K, Dodd S, Vargo JA, Subedi G, Xue J, Ebid B, Ehret F, Rhieu BA, Fürweger C, Grimm R, Muacevic A, Moiseenko V, Kalnicki S, McLaughlin M, Kleinberg LR, Adler JR, Gibbs IC. +24 moreeuropepmc +2 more sources